Abstract
Background
Occupational dermatoses caused by personal protective equipment (PPE) in the ongoing COVID-19 pandemic are emerging occupational health challenges that must be promptly and effectively addressed to ease burden on our health care workers.
Objective
A systematic review was conducted to determine common PPE-related dermatoses, affected body sites, and implicated occupational contactants. We further proposed solutions to mitigate this problem.
Methods
Online databases were searched for articles on PPE-related dermatoses in health care workers during the COVID-19 pandemic written in English and published from January 1, 2020, to January 30, 2021.
Results
Sixteen studies, including a total of 3958 participants, were included. The most common dermatoses were xerosis, pressure-related erythema, and contact dermatitis, mainly affecting the face and hands. The most widely implicated contactants were increased frequency of hand hygiene, gloves, N95 masks, and goggles. Proposed solutions were categorized as individual self-care, protection of the workforce, and long-term preventive measures.
Conclusion
Through measures such as regular basic skin care education, early access to specialty clinics via telemedicine, and designing of better-fit PPE, the challenges posed by PPE-related occupational dermatoses can be significantly reduced.
Key words: COVID-19, health care workers, occupational dermatoses, personal protective equipment
Abbreviations used: ACD, allergic contact dermatitis; HCW, health care workers; ICD, irritant contact dermatitis; PPE, personal protective equipment
Capsule Summary.
-
•
COVID-19–related occupational dermatoses present occupational health challenges that affect many health care workers (HCWs) worldwide.
-
•
Regular basic skin care education, early access to specialty clinics using telemedicine, and designing of better-fit PPE are feasible ways to mitigate the challenges faced by our frontline HCWs in the COVID-19 pandemic.
Introduction
COVID-19 has taken the world by storm and drastically affected the practice of virtually all health care workers (HCWs) across the globe. It was first declared a public health emergency of international concern by the World Health Organisation on January 30, 2020, and has since resulted in over 180 million reported cases and almost 4 million deaths worldwide.1 In many countries, HCWs have had to adapt to constantly changing policies, including strict regulations on the use of personal protective equipment (PPE). The use of PPE—measures such as wearing of gloves, N95 respirators, and protective suits and increased frequency of hand hygiene—institutes precautions to minimize the risk of viral transmission via respiratory droplets, aerosols, and excessive contact between individuals.2, 3, 4
It is well known that PPE usage, especially over prolonged periods, may result in occupational skin diseases.5, 6, 7, 8 Studies have shown that high incidences of PPE-related dermatoses, such as facial pressure injuries and hand dermatitis, occur during the ongoing COVID-19 pandemic.9, 10, 11, 12 These skin lesions can be a severe detriment to HCWs' morale, workability, and quality of life, with increased risk of subsequent psychologic burden.13 Seeking relief from such symptoms may cause inadvertent breaches of PPE, thereby increasing the risk of COVID-19 transmission.14,15
Therefore, there is a pressing need to find ways to facilitate the prevention and effective management of these skin conditions. However, to the best of our knowledge, few systematic reviews critically examining pooled data from the abovementioned studies, especially in the Asian population, have been conducted to date.
Our study aimed to address this unmet need via a comprehensive systematic review of the impact and burden of PPE-related dermatoses on HCWs worldwide. We reported the incidences of various skin lesions concerning increased PPE usage and proposed solutions to minimize the adverse skin reactions faced by our HCWs during this ongoing pandemic.
Materials and methods
The study protocol was registered with the PROSPERO register of systematic reviews.
The PubMed, OVID, EMBASE, MEDLINE, and Google Scholar databases were searched for relevant articles written in English and published from January 1, 2020, to January 30, 2021. The keywords “healthcare workers,” “rash,” “skin,” and “occupational,” in conjunction with the words “COVID-19” and “SARS-CoV-2,” were used. This initial search in the aforementioned databases yielded 174 articles. The number of articles included in our final analysis was scoped by removing duplicates, articles without original data, or articles that lacked direct relevance to HCWs, PPE, or cutaneous diseases (Fig 1).
Fig 1.
Summary of systematic review performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines.
The selection of articles for inclusion and data extraction was performed independently by 2 authors (Drs Keng and Oh). The following information was extracted from the included studies (where available): authors, region, age, site and type of skin conditions, occupational contactants, and proposed solutions. Any disagreements were resolved by a third independent author (Author Tam). A risk-of-bias assessment of all included studies was performed (Supplemental Material link on Mendeley: https://doi.org/10.17632/rddp6w27wf.1.) This systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Results
Sixteen articles were found suitable for inclusion in our review.9, 10, 11, 12, 13,16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26 These were largely cross-sectional studies with cohort sizes ranging from 7 to 542. A total of 3958 participants were described in these studies. The relevant findings are detailed in Table I, Table II, Table III, Table IV, Table V.
Table I.
Characteristics of PPE-related occupational dermatoses in HCWs during the COVID-19 pandemic
| Authors | Region/country | Study type, number with skin conditions/cohort size, and demographics (if reported) | Skin conditions | Occupational contactants |
|---|---|---|---|---|
| Lan et al9 | China | Cross-sectional study, n = 526/542 | Affected site: nasal bridge (83.1%), cheek (78.7%), hands (74.5%), and forehead (57.2%). | N95 masks (100%), goggles (83.2%), face shield (48.9%), and double-layered gloves + hand washing >10 times per day (59.2%) |
| Pei et al11 | China | Cross-sectional study, n = 354/484 | Symptoms: erythema (38.8%), prurigo (22.9%), blisters (13.8%), rhagades (13.6%), and papule or edema (12.8%). Affected site: face (47.1%), hands (27.5%), limbs (15.7%), trunk (12.6%), and whole body (2.3%). | PPE (100%): divided into biosafety level 1 (18.2%), level 2 (64.1%), and level 3 (17.2%) |
| Daye et al13 | Turkey | Cross-sectional study, n = 397/440, median age = 33.5 y, 131 physicians and 191 nurses | Symptoms: dryness (76.6%), itching (51.8%), flaking (40.2%), and tingling (29.8%). Affected site: hand surface (60.7%), nose bridge (40.7%), ears (28.4%), and cheeks (25.7%). | Masks with metal nose bridge (92.7%), gloves (76.1%), goggles (67.0%), and visors (37.0%) |
| Pourani et al26 | Iran | Cross-sectional study, n = 280/376, mean age = 32 y | Focused specifically only on hand contact urticaria (8.2%). | Use of PPE, including gloves (percentage not stated) |
| Lin et al25 | China | Cross-sectional study, n = 280/376, mean age = 32 y | Symptoms: dryness or scales (68.6%), papules or erythema (60.4%), and maceration (52.9%). Affected site: hands (84.6%), cheeks (75.4%), nasal bridge (71.8%). | Use of PPE (percentage not stated) and increased frequency of hand washing (100%) |
| O'Neill et al10 | UK | Cross -sectional study, n = 337/337 | Dermatosis determined to be occupational in 315/337 (93.5%). Clinical diagnoses: irritant contact dermatitis (59%), acne or rosacea (17%), atopic eczema (12%), allergic contact dermatitis (7%), and facial pressure injury (3%). | Use of PPE (percentage not stated) |
| Yan et al12 | China | Cross-sectional study, n = 234/330 | Seventy-one percent of participants reported skin barrier damage. Main symptoms: burning, itch, and stinging. Main types of lesions: dryness or scales, papules, erythema, and maceration. | Hand washing >10 times per d (66.1%), PPE use for >6 h per d (56.7%), and wearing 3 layers of gloves (12.4%) |
| Kiely et al16 | Ireland | Cross-sectional study, n = 223/270, 68 physicians and 140 nurses | Affected site: hands (76.5%), nose (13.7%), and cheeks (12.6%). Symptoms: dry skin (75.4%), redness (36.9%), and itching (27.6%). | Use of PPE (percentage not stated) and increased frequency of hand washing (99.3%) |
| Ferguson et al17 | UK | Cross-sectional study, n = 231/231, mean age 37 y | Affected site: hands (77.1%) and face (64.1%). Clinical diagnoses: irritant contact dermatitis (77.5%), suspected allergic contact dermatitis (18.6%), and atopic dermatitis (15.6%). | Use of masks, goggles, and gloves (percentage not stated) |
| Guertler et al18 | Germany | Cross-sectional study, n = 103/114, mean age = 35 y, 39 physicians and 75 nurses | Hand eczema (90.4%). Related symptoms: dryness (83.2%), erythema (38.6%), itching (28.9%), burning (21.1%), scaling (18.4%), fissures (9.6%), and pain (4.4%). | Hand washing >10 times per d (71.7%) |
| Erdem et al19 | Turkey | Cross-sectional study, n = 54/107, mean age = 29.6 y, 47 physicians and 48 nurses | Hand eczema characteristics (54/107): irritant contact dermatitis (96.3%) and morphology erythema-squamatous (75.9%). Localization: dorsum (85.2%), palm (20.4%), and finger webs (18.5%). | Hand washing >10 times per shift (81.2%) and glove use >10 times per shift (73.6%) |
| Mushtaq et al20∗ | India | Cross-sectional study, n = 101/101, mean age = 36.7 y, 46 HCWs | Symptoms: pruritus (45.5%), burning (46.5%), and stinging (6.9%). Morphology: erythema (79.2%), papules (60.4%), vesicles (17.8%), and xerosis (15.8%). Affected site: hands (72.3%), face (22.8%), and trunk (6.9%). Most common diagnosis: contact dermatitis (72.3%). | Culprit agents (not total prevalence of each): soap and water (56.4%), gloves (47.5%), sanitizer (38.6%), and mask (20.8%) |
| Chernyshov et al21 | Ukraine | Cohort study, n = 77/96, mean age 34 y, 31 physicians and 65 nurses | Hand-related symptoms: redness (80.2%), itch (75.0%), fissures (62.5%), oozing (20.8%), and vesiculation (10.4%). | Increased frequency of hand disinfection (100%) |
| Hadjieconomou et al22 | UK | Cross-sectional study, n = 72/72, mean age 43 y, 10 physicians and 21 nurses | Clinical diagnoses: irritant hand dermatitis (62.5%), worsening of pre-existing skin conditions (eg, eczema) (23.6%), and mask-related lesions (4%). | Increased frequency of hand washing and the use of alcohol-based hand sanitizers (percentage not stated) |
| Hu et al23 | China | Cross-sectional study, n = 61, 30 physicians and 31 nurses | Lesions due to N95 masks (58/61): nasal bridge scarring (68.9%), facial itching (27.9%), and skin damage (26.2%). Lesions due to latex gloves (54/61): dry skin (55.7%), itching (31.2%), and rash (23.0%). Lesions due to protective clothing (37/61): dry skin (36.1%), itching (34.4%), and rash (11.5%). | N95 masks (100%), latex gloves (100%), and protective clothing (100%) |
| Greveling et al24 | Netherlands | Case series, n = 7/7, mean age = 39 y | Hand eczema (100%). Symptoms: erythema, vesicles, itching, pain, rhagades, papules, desquamation, and bleeding. | Increased frequency of hand washing and the use of gloves (percentage not stated) |
HCW, Health care worker; PPE, personal protective equipment; UK, United Kingdom.
Photographs of the dermatoses are included in this article.
Table II.
Most commonly affected body sites (total cohort size n = 3958)
| Site | Specific area | n (%) |
|---|---|---|
| Face | Nose or nose bridge | 978 (24.7) |
| Cheeks | 845 (21.3) | |
| Forehead | 407 (10.3) | |
| Others or not specified | 707 (17.9) | |
| Hands | Palm | 109 (2.8) |
| Dorsum | 46 (1.2) | |
| Interdigital spaces | 104 (2.6) | |
| Others or not specified | 1853 (46.8) | |
| Trunk | 44 (1.1) | |
| Legs | 3 (0.1) | |
| Not specified | 573 (14.5) |
Table III.
Types of dermatosis (total cohort size n = 3958)
| Specific type of dermatosis | n (%) |
|---|---|
| Xerosis | 1094 (27.6) |
| Erythema | 876 (22.1) |
| Irritant contact dermatitis | 587 (14.8) |
| Maceration | 439 (11.1) |
| Fissures or erosions | 436 (11.0) |
| Vesicles or pustules | 205 (5.2) |
| Allergic contact dermatitis | 67 (1.7) |
| Others or not specified∗ | 1700 (43.0) |
May contain overlaps (double counting) within the same article.
Table IV.
Commonly implicated occupational contactants or PPE (total cohort size n = 3958)
| Occupational contactant | n (%)∗ |
|---|---|
| Increased frequency of hand hygiene† | 1915 (48.4) |
| Gloves | 1353 (34.2) |
| N95 masks | 1064 (26.9) |
| Goggles or face shields | 837 (21.1) |
| Gowns | 143 (3.6) |
| PPE use, but not specified | 2170 (54.8) |
PPE, Personal protective equipment.
Refers to the total number of health care workers using PPE, not limited to those with dermatoses.
Inclusive of soap and water as well as alcohol-based hand rubs.
Table V.
Proposed solutions
| Category | Specific solutions∗ |
|---|---|
| Protection and self-care of individuals | Regular use of emollients12,13,18,19,22, 23, 24 |
| Proper mask and PPE fitting12,13,17 | |
| Application of gauze at pressure areas before donning N95 mask12,22 | |
| Protection of the HCW workforce | Revision of working hours to allow skin rest9,13,24,25 |
| Education on common skin symptoms, basic treatment, and the importance of consistent skin care13,20,24 | |
| Early consultation with a dermatologist or occupational health specialist for persistent or severe cases12,24,25 | |
| Performance of patch testing in suspected cases of contact dermatitis17 | |
| Long-term protection and prevention | Telemedicine for quick and convenient consultations |
| Improved design of N95 masks to better fit Asian facial features and, hence, reduce facial pressure injuries | |
| Combination of moisturizers with alcohol-based hand rubs | |
| Use of less allergenic materials to make gloves23,24,26 | |
| Development of more situation-specific and comfortable PPE20 | |
| Use of QoL scores (such as DLQI) in evaluating the impact of interventions13,21 |
DLQI, Dermatology life quality index; HCW, health care worker; PPE, personal protective equipment; QoL, quality of life.
Numbers specify the references in which each solution was suggested, if any.
Table I summarizes the 16 studies included in our review.
Notably, one of the main findings across multiple articles9,11,20,25 was that a longer exposure duration to PPE showed a statistically significant positive association with adverse cutaneous reactions. Guertler et al18 performed a subgroup analysis between HCWs working directly with COVID-19 patients in an intensive care unit setting and those who did not, finding that hand hygiene practices and rates of hand dermatitis were largely comparable between the 2 groups. Chernyshov et al21 divided participants into 3 groups, 2 of which received different hand care products (gels and emollients), whereas the remaining group did not. Their findings were that participants in the intervention groups reported significantly enhanced dermatology life quality index scores and subjective improvement in symptoms after 1 month compared with the controls.
When the entire cohort was analyzed as a whole, the most commonly affected body sites included the face and hands (Table II). The trunk and legs were the least affected. Xerosis (27.6%), pressure-related erythema (22.1%), and irritant contact dermatitis (ICD) (14.8%) were the most common dermatologic manifestations (Table III). Of note, a few studies10,12 did not specifically describe the site or type of dermatosis encountered; 14.5% of the total study population did not report the affected body site.
Table IV shows that increased frequency of hand hygiene (48.4%) and use of gloves (34.2%), N95 masks (26.9%), and goggles or face shields (21.1%) were the most commonly implicated occupational contactants. Some papers10,16,17 did not directly specify the types of PPE used by HCWs in the study cohort.
Table V shows our proposed solutions to mitigate the effects of PPE-related occupational dermatoses on our HCWs. These were broadly divided into 3 categories: individual self-care, protection of the HCW workforce, and long-term preventive measures.
Discussion
Our review of the available literature revealed a few pertinent findings. First, there is a high prevalence of PPE-related occupational dermatoses affecting HCWs worldwide. The most commonly reported skin conditions are xerosis, pressure-related erythema, and contact dermatitis, and these primarily affect the face and hands of HCWs. The implicated occupational contactants include increased frequency of hand washing and the use of N95 masks, gloves, and goggles.
The PPE-related facial dermatoses include pressure-related skin injuries and mask-related acne. Pressure-related skin injuries are a frequent complication of wearing goggles and N95 masks, especially for long periods. These may initially manifest as erythema and skin indentation. If proper measures are not taken to protect the affected areas, they might progress to fissures, erosions, blisters, or ulcers.12,27 The sites that are particularly susceptible to pressure include the nasal bridge and cheeks.9,28 Additionally, skin maceration and abrasions at these sites might compromise the protective barrier and result in a secondary infection.29
Another commonly seen cutaneous manifestation is mask-related acne. The use of masks and goggles tends to cause excessive accumulation of sweat and sebum on the face due to increased heat and humidity. This effect may be even more pronounced in countries with tropical climates.30 Furthermore, friction and pressure due to repetitive mask wearing can also result in mechanical trauma, leading to rupture of microcomedones and occlusion of sebaceous ducts.9,31 Overall, this may exacerbate pre-existing acne vulgaris and result in the development of mechanical acneiform eruptions in those without a prior history.
It is widely known that hand hygiene is a critical measure for minimizing bacterial and viral spread. However, frequent hand hygiene also exposes the skin to friction and chemicals, which may cause loss of moisture and result in skin barrier damage,32 which manifests as xerotic changes in a large proportion of HCWs.9,12,25 This is true for both hand washing with soap and water as well as alcohol-based hand rubs.33
Occupational contact dermatitis affects not only HCWs but also other professionals who perform wet work, such as cleaners, dhobis, and plumbers. It can be largely divided into ICD and allergic contact dermatitis (ACD) and may be caused by glove materials (commonly rubber), hand cleansers, or inadequate hand drying before donning gloves.5,34, 35, 36, 37 ICD accounts for nearly 80% of cases, featuring predominant symptoms of burning, stinging, and soreness, whereas ACD is more uncommon and usually presents as pruritus. The management of ICD involves selecting less irritating hand hygiene products and the consistent use of emollients, whereas the cornerstone of ACD treatment is the identification and avoidance of the contact allergen.38 The incidence of contact dermatitis is significantly associated with the duration and intensity of contact with the agent in question.39
Proposed solutions
We broadly classified our proposed solutions into 3 categories (Table V). The first is self-care measures that HCWs may consider for their protection and comfort. The second is organizational-level recommendations targeted at improving the welfare of the workforce as a whole. Finally, the third category includes longer-term measures, which may require further research efforts or logistical planning before being put into practice.
Individual self-care
The consistent application of emollients is an often-cited and easily attainable way of minimizing skin damage due to xerosis caused by frequent hand hygiene12,13,18,19 but is still severely lacking in practice. Kiely et al16 reported that over 99% of HCWs in their study increased their hand hygiene frequency in response to COVID-19, but 45% did not use any moisturizers. Indeed, it has been shown that emollients are critical for repairing skin barrier damage and do not compromise the efficacy of hand washing or alcohol-based hand rubs.40,41 In severe or refractory cases, topical and, sometimes, oral glucocorticoid agents may even play a role in reducing inflammation, and ample time should be given for damaged skin to recover before the resumption of clinical duties. Furthermore, the study by Chernyshov et al21 indicated that direct the provision of emollients to HCWs, as opposed to simply advising them on skin care education, may be far better in encouraging the diligent use of such products. We, therefore, recommend that health care institutions consider providing emollients to HCWs, especially those who face prolonged working hours in PPE.
Proper mask and PPE fitting is another key way of minimizing skin damage, in particular, pressure injuries, while maintaining adequate protection against viral transmission. Many studies have cited facial pressure injuries due to the use of overly tight-fitting N95 masks or goggles.12,13,17 Gowns should also not be too restrictive to cause friction-related injuries during movement. Furthermore, practices such as double-gowning or double-gloving may further trap moisture and, hence, increase skin exposure to heat and sweat, causing epidermal injury and worsening dermatitis.42,43
Related to the aforementioned pressure injuries, the application of gauze or hydrocolloid dressings over pressure areas before donning N95 masks may help relieve symptoms.12,22 Research to develop better methods of incorporating these protective measures into the N95 mask design is ongoing.44,45 We suggest that proper PPE fitting be accorded priority to protect the occupational health of the health care workforce. HCWs also have the option of applying hydrocolloid dressings as necessary to minimize pressure injuries, but the use of this may require another N95 mask fitment test to ensure the continued efficacy of PPE protection.
The constant contact pressure and friction due to PPE, such as N95 masks and goggles, can cause or aggravate pre-existing acne vulgaris.27 HCWs should take regular breaks from masks and goggles in order to minimize friction and pressure on the facial skin.27 For HCWs in whom comedogenic acne develops because of PPE, topical retinoids can be prescribed.46 HCWs with papulopustular acne due to PPE can be prescribed a combination of topical therapy, including retinoids, benzoyl peroxide, and topical antibiotic therapy, followed by a systemic antibiotic combination as a second-line treatment.46 For HCWs with moderate nodular acne due to PPE, oral retinoids can be prescribed if the aforementioned combination therapy fails.46
Protection of the health care workforce
Moderating the duration of time in PPE and allowing sufficient skin rest are critical for reducing the incidence of occupational dermatoses. Associations between long working hours in PPE and adverse cutaneous reactions have been demonstrated in multiple studies.9,11,20 Lan et al9 found that HCWs wearing N95 masks and goggles for more than 6 hours had significantly increased prevalence of skin damage on the cheeks and nasal bridge (P < .01) compared with their counterparts who donned this equipment for less than 6 hours. Prolonged exposure to irritant substances, sweat, and humidity exacerbates many forms of skin disease, including acne, folliculitis, and contact dermatitis.30,42,47 We suggest that shift work in full PPE be limited to 6 hours or fewer wherever possible and that HCWs be allowed breaks in well-distanced and well-ventilated areas where they can remove their PPE and rest.
Another important aspect of protecting our workforce would be educating HCWs on identifying cutaneous symptoms, basic skin care, and seeking further treatment if indicated.13,20,24 Because of busy schedules and heavy workloads, many HCWs tend to ignore early warning signs, such as mild erythema, or neglect daily skin care practices. This is further exacerbated by the current climate of stress and anxiety due to COVID-19, which may even cause feelings of depression or burnout.48,49 We must remind our workforce to care for their well-being even while serving others. Such information can be disseminated on virtual platforms, such as webinars, and subsequently reinforced via physical cues, such as placing bottles of moisturizers at areas where PPE is donned or doffed.
Consultation with a dermatologist or occupational health specialist should be readily available for severe or recalcitrant cases.12,24 These specialists may be able to diagnose and prescribe individualized treatments for certain dermatoses—for instance, topical retinoids and benzoyl peroxide for mild cases of acne vulgaris and systemic therapy for severe acne vulgaris46 or antihistamines for pressure urticaria.50 Patch testing may also be a consideration, especially to exclude cases of ACD; in glove-related cases of ACD, a contact allergy to rubber additives is the most common.51 Patch testing allows the identification of the culprit allergen in a structured manner.52
Long-term prevention
One of the ways to minimize the incidence of occupational dermatoses in the long term is to improve the design and functionality of our current PPE. Discomfort caused by ill-fitting PPE is known to cause inadvertent breaches of PPE, putting HCWs at increased risk of exposure to pathogens.15 To combat this, the research and development of more fit-for-purpose, customized, and comfortable PPE can be explored,20 These include using less allergenic materials, such as cotton or plastic to make gloves,23,24 adapting N95 mask designs to better conform to facial structures in specific populations, and combining moisturizers with cleansing hand rubs into a single formulation.
Telemedicine is a burgeoning field that may be able to assist in facilitating timely consultations for occupational skin issues.53,54 The benefits of telemedicine in this regard are twofold. First, it may be more convenient for time-strapped HCWs to seek such consultations as opposed to physical face-to-face clinic visits. Second, in this pandemic era of social distancing and minimizing physical contact, it would be seen as a welcome avenue to seek medical aid. In select disciplines and patient populations, studies have shown that telemedicine does not compromise the quality of consultations and may even reduce wait times while improving patient satisfaction.55,56 A recent systematic review further demonstrated that the use of telemedicine in dermatology has been on the rise during the current pandemic and that a majority of studies found teledermatology to be a useful and convenient tool for managing common ambulatory dermatoses.57
Finally, health care institutions can consider using quality-of-life measures, such as the dermatology life quality index, to evaluate the burden caused by occupational skin disease. The dermatology life quality index, in particular, has been validated and used in multiple studies, providing an alternative dimension to assess the impact on function.13,21,58, 59, 60 Furthermore, it may be longitudinally used to evaluate the impact of controlled interventions. Exploring the impact of dermatologic disease on aspects such as choice of clothing, participation in recreational activities, and relationships with others allows a more holistic assessment.61,62
Conclusion
As the campaign against COVID-19 continues to rage on across the globe, our health care policies and practices must continually adapt. There is a likelihood that PPE regulations such as the mandatory donning of N95 masks may become the new normal. Therefore, seeking sustainable solutions to mitigate the burden of PPE-related occupational dermatoses is an endeavor that should not be neglected. With proper guidelines in place and a concerted effort by various stakeholders, this challenge can be overcome.
Conflicts of interest
None disclosed.
Footnotes
Funding sources: None.
IRB approval status: Not required as per the institutional policy of Singapore General Hospital.
References
- 1.World Health Organization; 2021. WHO coronavirus (COVID-19) dashboard.https://covid19.who.int [Google Scholar]
- 2.Cook T.M. Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic—a narrative review. Anaesthesia. 2020;75(7):920–927. doi: 10.1111/anae.15071. [DOI] [PubMed] [Google Scholar]
- 3.Honda H., Iwata K. Personal protective equipment and improving compliance among healthcare workers in high-risk settings. Curr Opin Infect Dis. 2016;29(4):400–406. doi: 10.1097/QCO.0000000000000280. [DOI] [PubMed] [Google Scholar]
- 4.Tian Z., Stedman M., Whyte M., Anderson S.G., Thomson G., Heald A. Personal protective equipment (PPE) and infection among healthcare workers—what is the evidence? Int J Clin Pract. 2020;74(11):e13617. doi: 10.1111/ijcp.13617. [DOI] [PubMed] [Google Scholar]
- 5.Araghi F., Tabary M., Gheisari M., Abdollahimajd F., Dadkhahfar S. Hand hygiene among health care workers during COVID-19 pandemic: challenges and recommendations. Dermatitis. 2020;31(4):233–237. doi: 10.1097/DER.0000000000000639. [DOI] [PubMed] [Google Scholar]
- 6.Di Altobrando A., La Placa M., Neri I., Piraccini B.M., Vincenzi C. Contact dermatitis due to masks and respirators during COVID-19 pandemic: what we should know and what we should do. Dermatol Ther. 2020;33(6):e14528. doi: 10.1111/dth.14528. [DOI] [PubMed] [Google Scholar]
- 7.Foo C.C., Goon A.T., Leow Y.H., Goh C.L. Adverse skin reactions to personal protective equipment against severe acute respiratory syndrome—a descriptive study in Singapore. Contact Derm. 2006;55(5):291–294. doi: 10.1111/j.1600-0536.2006.00953.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Long H., Zhao H., Chen A., Yao Z., Cheng B., Lu Q. Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China. J Eur Acad Dermatol Venereol. 2020;34(5):919–921. doi: 10.1111/jdv.16388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lan J., Song Z., Miao X. Skin damage among health care workers managing coronavirus disease-2019. J Am Acad Dermatol. 2020;82(5):1215–1216. doi: 10.1016/j.jaad.2020.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.O'Neill H., Narang I., Buckley D.A. Occupational dermatoses during the COVID-19 pandemic: a multicentre audit in the UK and Ireland. Br J Dermatol. 2021;184(3):575–577. doi: 10.1111/bjd.19632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pei S., Xue Y., Zhao S. Occupational skin conditions on the front line: a survey among 484 Chinese healthcare professionals caring for Covid-19 patients. J Eur Acad Dermatol Venereol. 2020;34(8):e354–e357. doi: 10.1111/jdv.16570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Yan Y., Chen H., Chen L. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019. Dermatol Ther. 2020;33(4):e13310. doi: 10.1111/dth.13310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Daye M., Cihan F.G., Durduran Y. Evaluation of skin problems and dermatology life quality index in health care workers who use personal protection measures during COVID-19 pandemic. Dermatol Ther. 2020;33(6):e14346. doi: 10.1111/dth.14346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Arora P., Sardana K., Sinha S. Real-world assessment, relevance, and problems in use of personal protective equipment in clinical dermatology practice in a COVID referral tertiary hospital. J Cosmet Dermatol. 2020;19(12):3189–3198. doi: 10.1111/jocd.13736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kantor J. Behavioral considerations and impact on personal protective equipment use: early lessons from the coronavirus (COVID-19) pandemic. J Am Acad Dermatol. 2020;82(5):1087–1088. doi: 10.1016/j.jaad.2020.03.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kiely L.F., Moloney E., O'Sullivan G., Eustace J.A., Gallagher J., Bourke J.F. Irritant contact dermatitis in healthcare workers as a result of the COVID-19 pandemic: a cross-sectional study. Clin Exp Dermatol. 2021;46(1):142–144. doi: 10.1111/ced.14397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ferguson F.J., Street G., Cunningham L., White I.R., McFadden J.P., Williams J. Occupational dermatology in the time of the COVID-19 pandemic: a report of experience from London and Manchester, UK. Br J Dermatol. 2021;184(1):180–182. doi: 10.1111/bjd.19482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Guertler A., Moellhoff N., Schenck T.L. Onset of occupational hand eczema among healthcare workers during the SARS-CoV-2 pandemic: comparing a single surgical site with a COVID-19 intensive care unit. Contact Derm. 2020;83(2):108–114. doi: 10.1111/cod.13618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Erdem Y., Altunay I.K., Cerman A.A. The risk of hand eczema in healthcare workers during the COVID-19 pandemic: do we need specific attention or prevention strategies? Contact Derm. 2020;83(5):422–423. doi: 10.1111/cod.13632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Mushtaq S., Terzi E., Recalcati S., Salas-Alanis J.C., Amin S., Faizi N. Cutaneous adverse effects due to personal protective measures during COVID-19 pandemic: a study of 101 patients. Int J Dermatol. 2021;60(3):327–331. doi: 10.1111/ijd.15354. [DOI] [PubMed] [Google Scholar]
- 21.Chernyshov P.V., Kolodzinska L. Prospective study on hand dermatitis in nurses and doctors during COVID-19 pandemic and its improvement by use of adopted recommendations of the European Academy of Dermatology and Venereology Task Force on Contact Dermatitis. Dermatol Ther. 2020;33(6):e14396. doi: 10.1111/dth.14396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hadjieconomou S., Hughes J., Kamath S. Occupational skin disease during the COVID-19 pandemic, as captured in a dermatology staff clinic in the United Kingdom. J Eur Acad Dermatol Venereol. 2020;34(11):e670–e671. doi: 10.1111/jdv.16754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hu K., Fan J., Li X., Gou X., Li X., Zhou X. The adverse skin reactions of health care workers using personal protective equipment for COVID-19. Medicine. 2020;99(24):e20603. doi: 10.1097/MD.0000000000020603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Greveling K., Kunkeler A.C. Hand eczema pandemic caused by severe acute respiratory syndrome coronavirus 2 hygiene measures: the set-up of a hand eczema helpline for hospital personnel. J Eur Acad Dermatol Venereol. 2020;34(10):e556–e557. doi: 10.1111/jdv.16695. [DOI] [PubMed] [Google Scholar]
- 25.Lin P., Zhu S., Huang Y. Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regions. Br J Dermatol. 2020;183(1):190–192. doi: 10.1111/bjd.19089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Pourani M.R., Nasiri S., Abdollahimajd F. Prevalence of hand contact urticaria and related risk factors among healthcare workers during the COVID-19 pandemic: a self-reported assessment. Dermatol Ther. 2020;33(6):e14367. doi: 10.1111/dth.14367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Lee H.C., Goh C.L. Occupational dermatoses from personal protective equipment during the COVID-19 pandemic in the tropics—a review. J Eur Acad Dermatol Venereol. 2021;35(3):589–596. doi: 10.1111/jdv.16925. [DOI] [PubMed] [Google Scholar]
- 28.Singh M., Pawar M., Bothra A. Personal protective equipment induced facial dermatoses in healthcare workers managing Coronavirus disease 2019. J Eur Acad Dermatol Venereol. 2020;34(8):e378–e380. doi: 10.1111/jdv.16628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Matar S., Oules B., Sohier P. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature. J Eur Acad Dermatol Venereol. 2020;34(11):e686–e689. doi: 10.1111/jdv.16775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Narang I., Sardana K., Bajpai R., Garg V.K. Seasonal aggravation of acne in summers and the effect of temperature and humidity in a study in a tropical setting. J Cosmet Dermatol. 2019;18(4):1098–1104. doi: 10.1111/jocd.12777. [DOI] [PubMed] [Google Scholar]
- 31.Tan K.T., Greaves M.W. N95 acne. Int J Dermatol. 2004;43(7):522–523. doi: 10.1111/j.1365-4632.2004.02338.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Visscher M.O., Randall Wickett R. Hand hygiene compliance and irritant dermatitis: a juxtaposition of healthcare issues. Int J Cosmet Sci. 2012;34(5):402–415. doi: 10.1111/j.1468-2494.2012.00733.x. [DOI] [PubMed] [Google Scholar]
- 33.Rocha L.A., e Borges L.F., Gontijo Filho P.P. Changes in hands microbiota associated with skin damage because of hand hygiene procedures on the health care workers. Am J Infect Control. 2009;37(2):155–159. doi: 10.1016/j.ajic.2008.04.251. [DOI] [PubMed] [Google Scholar]
- 34.Herloch V., Elsner P. The (new) occupational disease no. 5101: “Severe or recurrent skin diseases”. J Dtsch Dermatol Ges. 2021;19(5):720–741. doi: 10.1111/ddg.14537. [DOI] [PubMed] [Google Scholar]
- 35.Jindal R., Pandhi D. Hand hygiene practices and risk and prevention of hand eczema during the COVID-19 pandemic. Indian Dermatol Online J. 2020;11(4):540–543. doi: 10.4103/idoj.IDOJ_448_20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kendziora B., Guertler A., Stander L. Evaluation of hand hygiene and onset of hand eczema after the outbreak of SARS-CoV-2 in Munich. Eur J Dermatol. 2020;30(6):668–673. doi: 10.1684/ejd.2020.3923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Diepgen T.L., Andersen K.E., Chosidow O. Guidelines for diagnosis, prevention and treatment of hand eczema. J Dtsch Dermatol Ges. 2015;13(1):e1–e22. doi: 10.1111/ddg.12510_1. [DOI] [PubMed] [Google Scholar]
- 38.Tan S.W., Oh C.C. Contact dermatitis from hand hygiene practices in the COVID-19 pandemic. Ann Acad Med Singap. 2020;49(9):674–676. [PubMed] [Google Scholar]
- 39.Clark S.C., Zirwas M.J. Management of occupational dermatitis. Dermatol Clin. 2009;27(3):365–383. doi: 10.1016/j.det.2009.05.002. [DOI] [PubMed] [Google Scholar]
- 40.Balato A., Ayala F., Bruze M. European Task Force on Contact Dermatitis statement on coronavirus disease-19 (COVID-19) outbreak and the risk of adverse cutaneous reactions. J Eur Acad Dermatol Venereol. 2020;34(8):e353–e354. doi: 10.1111/jdv.16557. [DOI] [PubMed] [Google Scholar]
- 41.Beiu C., Mihai M., Popa L., Cima L., Popescu M.N. Frequent hand washing for COVID-19 prevention can cause hand dermatitis: management tips. Cureus. 2020;12(4):e7506. doi: 10.7759/cureus.7506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Mehta R.D., Bumb R.A. Sweat dermatitis. Int J Dermatol. 2000;39(11):872. doi: 10.1046/j.1365-4362.2000.00914.x. [DOI] [PubMed] [Google Scholar]
- 43.Takahagi S., Tanaka A., Hide M. Sweat allergy. Allergol Int. 2018;67(4):435–441. doi: 10.1016/j.alit.2018.07.002. [DOI] [PubMed] [Google Scholar]
- 44.Field M.H., Rashbrook J.P., Rodrigues J.N. Hydrocolloid dressing strip over bridge of nose to relieve pain and pressure from filtered face piece (FFP) masks during the coronavirus (COVID-19) pandemic. Ann R Coll Surg Engl. 2020;102(5):394–396. doi: 10.1308/rcsann.2020.0095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.de Vera J.D., Alcalde S.R., Carretero J.C., Garcia M.B. The preventive effect of hydrocolloid dressing to prevent facial pressure and facial marks during use of medical protective equipment in COVID-19 pandemic. Br J Oral Maxillofac Surg. 2020;58(6):723–725. doi: 10.1016/j.bjoms.2020.04.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Conforti C., Chello C., Giuffrida R., di Meo N., Zalaudek I., Dianzani C. An overview of treatment options for mild-to-moderate acne based on American Academy of Dermatology, European Academy of Dermatology and Venereology, and Italian Society of Dermatology and Venereology guidelines. Dermatol Ther. 2020;33(4):e13548. doi: 10.1111/dth.13548. [DOI] [PubMed] [Google Scholar]
- 47.Kubo A., Nagao K., Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest. 2012;122(2):440–447. doi: 10.1172/JCI57416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Aly H.M., Nemr N.A., Kishk R.M., Elsaid N. Stress, anxiety and depression among healthcare workers facing COVID-19 pandemic in Egypt: a cross-sectional online-based study. BMJ Open. 2021;11(4):e045281. doi: 10.1136/bmjopen-2020-045281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Yildirim M., Cicek I., Sanli M.E. Coronavirus stress and COVID-19 burnout among healthcare staffs: the mediating role of optimism and social connectedness. Curr Psychol. 2021:1–9. doi: 10.1007/s12144-021-01781-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Kulthanan K., Ungprasert P., Tuchinda P., Chularojanamontri L., Charoenpipatsin N., Maurer M. Delayed pressure urticaria: a systematic review of treatment options. J Allergy Clin Immunol Pract. 2020;8(6):2035–2049. doi: 10.1016/j.jaip.2020.03.004. [DOI] [PubMed] [Google Scholar]
- 51.Hamnerius N., Svedman C., Bergendorff O. Hand eczema and occupational contact allergies in healthcare workers with a focus on rubber additives. Contact Derm. 2018;79(3):149–156. doi: 10.1111/cod.13042. [DOI] [PubMed] [Google Scholar]
- 52.Jamiolkowski D., Steveling-Klein E., Thomas Z.M., Bircher A., Hofmeier K.S., Hartmann K. Structured diagnostic assessment of hand eczema in cleaning workers. J Dtsch Dermatol Ges. 2021;19(5):672–676. doi: 10.1111/ddg.14452. [DOI] [PubMed] [Google Scholar]
- 53.Trettel A., Eissing L., Augustin M. Telemedicine in dermatology: findings and experiences worldwide—a systematic literature review. J Eur Acad Dermatol Venereol. 2018;32(2):215–224. doi: 10.1111/jdv.14341. [DOI] [PubMed] [Google Scholar]
- 54.Trinidad J., Kroshinsky D., Kaffenberger B.H., Rojek N.W. Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic. J Am Acad Dermatol. 2020;83(1):e69–e71. doi: 10.1016/j.jaad.2020.04.096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Costanzo M.C., Arcidiacono C., Rodolico A., Panebianco M., Aguglia E., Signorelli M.S. Diagnostic and interventional implications of telemedicine in Alzheimer's disease and mild cognitive impairment: a literature review. Int J Geriatr Psychiatry. 2020;35(1):12–28. doi: 10.1002/gps.5219. [DOI] [PubMed] [Google Scholar]
- 56.Rogers G. Using telemedicine for pediatric preanesthesia evaluation: a pilot project. J Perianesth Nurs. 2020;35(1):3–6. doi: 10.1016/j.jopan.2019.07.001. [DOI] [PubMed] [Google Scholar]
- 57.Loh C.H., Chong Tam S.Y., Oh C.C. Teledermatology in the COVID-19 pandemic: a systematic review. JAAD Int. 2021;5:54–64. doi: 10.1016/j.jdin.2021.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Basra M.K., Fenech R., Gatt R.M., Salek M.S., Finlay A.Y. The dermatology life quality index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159(5):997–1035. doi: 10.1111/j.1365-2133.2008.08832.x. [DOI] [PubMed] [Google Scholar]
- 59.Finlay A.Y., Khan G.K. Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216. doi: 10.1111/j.1365-2230.1994.tb01167.x. [DOI] [PubMed] [Google Scholar]
- 60.Reilly M.C., Lavin P.T., Kahler K.H., Pariser D.M. Validation of the dermatology life quality index and the work productivity and activity impairment-chronic hand dermatitis questionnaire in chronic hand dermatitis. J Am Acad Dermatol. 2003;48(1):128–130. doi: 10.1067/mjd.2003.128. [DOI] [PubMed] [Google Scholar]
- 61.Ali F.M., Johns N., Salek S., Finlay A.Y. Correlating the dermatology life quality index with psychiatric measures: a systematic review. Clin Dermatol. 2018;36(6):691–697. doi: 10.1016/j.clindermatol.2018.08.014. [DOI] [PubMed] [Google Scholar]
- 62.Rhee J.S., Matthews B.A., Neuburg M., Smith T.L., Burzynski M., Nattinger A.B. Skin cancer and quality of life: assessment with the dermatology life quality index. Dermatol Surg. 2004;30(4):525–529. doi: 10.1111/j.1524-4725.2004.30169.x. [DOI] [PubMed] [Google Scholar]

